<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>MicroRNA-106b Regulates Expression of the Tumour Suppressors p21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="MicroRNA-106b Regulates Expression of the Tumour Suppressors p21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e7/9234987/7019229f8b0b/ActaDV-100-16-5824-g001.jpg"/> </div> <div class="text-side"> <h1>MicroRNA-106b Regulates Expression of the Tumour Suppressors p21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides.</h1> <p>In situ hybridization of miR-106b in skin biopsies from patients with mycosis fungoides. (a–c) In situ hybridization of miR-106b stained positive in the dermal lymphocytes and surrounding stroma (b) (original magnification ×10) and (c) (original magnification ×40) compared with the scramble control (a) (original magnification ×10). (d–f) Double immunofluorescence staining of miR-106b and CD4 revealed that miR-106b is expressed in T-lymphocytes (original magnification ×10). (d) Double miR-106b and CD4 staining. (e, f) Single immunofluorescence staining of miR-106b and CD4, respectively. (g–i) Double miR-106b and CD4 staining (g) and single miR-106b (h) and CD4 (i) (original magnification ×40).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32556351/" target="_blank">32556351</a></p><p>Type: Premalignant/Malignant, Category: Hematolymphoid</p>
</div> </div></div></body></html>